Hyperfibrotic myelodysplasia: Case report with response to steroid therapy

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 38, Issue 2, 2002, Pages 149-151

  Romeo, Maura ^a   Chauffaille, Maria De Lourdes Lopes Ferrari ^a   Bahia, Daniella Marcia Maranhão ^a   Silva, Maria Regina Regis ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hyperfibrotic; Myelodysplastic syndromes; Steroid therapy

Indexed keywords

EID: 52649136065     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442002000200012     Document Type: Article

References (6)

1. Greenberg, P. et al. International Scoring System for evaluating prognosis in myelodysplastic syndrome. Blood, 89: 2079-88, 1997,
2. erratum Blood, 91: 1100, 1998.
3. Lambertenghi-Deliliers, G. et al. Myelodysplastic syndrome with increase marrow fibrosis: a distinct clinical-pathological entity. Br. J. Haematol., 78:161-6, 1991.
4. Manoharan, A.; Horsley R. & Pitney W.R. The reticulin content of bone marrow in acute leukemia in adults. Br. J. Haematol., 43: 185-90, 1979.
5. Pagliuca, A. et al. Myelofibrosis in primary myelodysplastic syndrome: a clinic-morphological study of 10 cases. Br. J. Haematol., 71: 499-504, 1989.
6. Watts, E.J. et al. Hyperfibrotic myelodysplasia: a report of three cases showing haematological remisson following treatment with prednisolone. Br. J. Haematol., 78: 120-4, 1991.